|
1
|
Fodstad O, Aass N and Pihl A: An inverse
relationship between the growth rate of human melanoma xenografts
and their response to some cytostatic drugs. Br J Cancer.
41:829–831. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Farahmand AM, Ehsani AH, Mirzaei M,
Mohsenian M and Ghanadan A: Patients' characteristics,
histopathological findings, and tumor stage in different types of
malignant melanoma: A retrospective multicenter study. Acta Med
Iran. 55:316–323. 2017.PubMed/NCBI
|
|
3
|
Hu DN, Yu GP and McCormick SA:
Population-based incidence of vulvar and vaginal melanoma in
various races and ethnic groups with comparisons to other
site-specific melanomas. Melanoma Res. 20:153–158. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Del Vecchio M: AACR update on 5-year
survival rates, effcacy and long-term safety in previously treated
advanced/metastatic melanoma patients receiving mono-immunotherapy
with nivolumab. Recenti Prog Med. 107:414–417. 2016.(In Italian).
PubMed/NCBI
|
|
5
|
Morton DL, Davtyan DG, Wanek LA, Foshag LJ
and Cochran AJ: Multivariate analysis of the relationship between
survival and the microstage of primary melanoma by Clark level and
Breslow thickness. Cancer. 71:3737–3743. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pfahlberg A, Kölmel KF and Gefeller O;
Febim Study Group, : Timing of excessive ultraviolet radiation and
melanoma: Epidemiology does not support the existence of a critical
period of high susceptibility to solar ultraviolet
radiation-induced melanoma. Br J Dermatol. 144:471–475. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Thoelke A, Willrodt S, Hauschild A and
Schadendorf D: Primary extracutaneous malignant melanoma: A
comprehensive review with emphasis on treatment. Onkologie.
27:492–499. 2004.PubMed/NCBI
|
|
8
|
Gasparini G: Tamoxifen and chemotherapy in
the treatment of metastatic melanoma: Are there other possible
mechanisms explaining their potentiation? J Clin Oncol.
12:1994–1996. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang X, Moschos SJ and Becker D:
Functional analysis and molecular targeting of aurora kinases a and
B in advanced melanoma. Genes Cancer. 1:952–963. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chi Z, Li S, Sheng X, Si L and Guo J:
Clinical presentation, histology, and prognoses of malignant
melanoma in ethnic Chinese: A study of 522 consecutive cases. BMC
Cancer. 11:852011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Barth A, Wanek L and Morton DL: Prognostic
factors in 1,521 melanoma patients with distant metastases. J Am
Coll Surg. 181:193–201. 1995.PubMed/NCBI
|
|
12
|
Ribero S, Glass D and Bataille V: Genetic
epidemiology of melanoma. Eur J Dermatol. 26:335–339. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Schmidt K, Joyce CE, Buquicchio F, Brown
A, Ritz J, Distel RJ, Yoon CH and Novina CD: The lncRNA SLNCR1
mediates melanoma invasion through a conserved SRA1-like region.
Cell Rep. 15:2025–2037. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gong J, Zhang H, He L, Wang L and Wang J:
Increased expression of long non-coding RNA BCAR4 is predictive of
poor prognosis in patients with non-small cell lung cancer. Tohoku
J Exp Med. 241:29–34. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wei F, Yang L, Jiang D, Pan M, Tang G,
Huang M and Zhang J: Long noncoding RNA DUXAP8 contributes to the
progression of hepatocellular carcinoma via regulating
miR-422a/PDK2 axis. Cancer Med. 9:2480–2490. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ji X, Tao R, Sun LY, Xu XL and Ling W:
Down-regulation of long non-coding RNA DUXAP8 suppresses
proliferation, metastasis and EMT by modulating miR-498 through
TRIM44-mediated AKT/mTOR pathway in non-small-cell lung cancer. Eur
Rev Med Pharmacol Sci. 24:3152–3165. 2020.PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sun M, Nie FQ, Zang C, Wang Y, Hou J, Wei
C, Li W, He X and Lu KH: The pseudogene DUXAP8 promotes
non-small-cell lung cancer cell proliferation and invasion by
epigenetically silencing EGR1 and RHOB. Mol Ther. 25:739–751. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ma HW, Xie M, Sun M, Chen TY, Jin RR, Ma
TS, Chen QN, Zhang EB, He XZ, De W and Zhang ZH: The pseudogene
derived long noncoding RNA DUXAP8 promotes gastric cancer cell
proliferation and migration via epigenetically silencing PLEKHO1
expression. Oncotarget. 8:52211–52224. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xu X, Xu Y, Shi C, Wang B, Yu X, Zou Y and
Hu T: A genome-wide comprehensively analyses of long noncoding RNA
profiling and metastasis associated lncRNAs in renal cell
carcinoma. Oncotarget. 8:87773–87781. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Goundiam O, Nagel MD and Vayssade M: Akt
and RhoA inhibition promotes anoikis of aggregated B16F10 melanoma
cells. Cell Biol Int. 36:311–319. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Delmas A, Cherier J, Medale-Giamarchi C,
Pradines A and Favre G: Abstract 3401: Vemurafenib-induced RhoB
expression leads to melanoma cell resistance. Cancer Res. 73 (Suppl
8):S34012013.
|
|
23
|
Eide A: The role of the sub-commission on
promotion and protection of human rights and its working groups in
the prevention of conflicts. Int J Minor Group Rights. 8:25–29.
2001. View Article : Google Scholar
|
|
24
|
Gao K, Zhou H, Zhang L, Lee JW, Zhou Q, Hu
S, Farrell J, Eibl G and Wong D: Abstract #314: Induction of
systemic disease-specific salivary biomarker profiles in mouse
models of melanoma and non-small cell lung cancer. Cancer Res. 69
(Suppl 9):S3142009.
|
|
25
|
Razaviyan J, Hadavi R, Tavakoli R, Kamani
F, Paknejad M and Mohammadi-Yeganeh S: Expression of miRNAs
targeting mTOR and S6K1 genes of mTOR signaling pathway including
miR-96, miR-557, and miR-3182 in triple-negative breast cancer.
Appl Biochem Biotechnol. 186:1074–1089. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhu KP, Ma XL and Zhang CL: LncRNA ODRUL
contributes to osteosarcoma progression through the miR-3182/MMP2
axis. Mol Ther. 25:2383–2393. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xue M, Shi D, Xu G and Wang W: The long
noncoding RNA linc00858 promotes progress of lung cancer through
miR-3182/MMP2 axis. Artif Cells Nanomed Biotechnol. 47:2091–2097.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhou MY, Lan GP, Si YF and Mo XG:
Expression patterns and significances of distant metastasis and
prognosis of MiR-3182 innasopharygeal carcinoma. Chin J New Clin
Med. 5:369–372. 2016.
|
|
29
|
Zhao G, Han X, Zheng S, Li Z, Sha Y, Ni J,
Sun Z, Qiao S and Song Z: Curcumin induces autophagy, inhibits
proliferation and invasion by downregulating AKT/mTOR signaling
pathway in human melanoma cells. Oncol Rep. 35:1065–1074. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Guo X, Wang W, Hu J, Feng K, Pan Y, Zhang
L and Feng Y: Lentivirus-mediated RNAi knockdown of NUPR1 inhibits
human nonsmall cell lung cancer growth in vitro and in vivo. Anat
Rec (Hoboken). 295:2114–2121. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cano CE, Hamidi T, Garcia MN, Grasso D,
Loncle C, Garcia S, Calvo E, Lomberk G, Dusetti N, Bartholin L, et
al: Genetic inactivation of Nupr1 acts as a dominant suppressor
event in a two-hit model of pancreatic carcinogenesis. Gut.
63:984–995. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Emma MR, Iovanna JL, Bachvarov D, Puleio
R, Loria GR, Augello G, Candido S, Libra M, Gulino A, Cancila V, et
al: NUPR1, a new target in liver cancer: Implication in controlling
cell growth, migration, invasion and sorafenib resistance. Cell
Death Dis. 7:e22692016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Boregowda RK, Olabisi OO, Abushahba W,
Jeong BS, Haenssen KK, Chen W, Chekmareva M, Lasfar A, Foran DJ,
Goydos JS and Cohen-Solal KA: RUNX2 is overexpressed in melanoma
cells and mediates their migration and invasion. Cancer Lett.
348:61–70. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wu H, Goel V and Haluska FG: PTEN
signaling pathways in melanoma. Oncogene. 22:3113–3122. 2003.
View Article : Google Scholar : PubMed/NCBI
|
